Wegovy, the popular obesity drug, may have yet another surprising benefit
Everything can be handled over the phone through telehealth, and your personalized compounded semaglutide is shipped to your door anywhere in Florida
If you are considering it, go in with clear eyes
The long-term effects of semaglutide are generally positive for people with type 2 diabetes and obesity who use it as prescribed by their healthcare provider
Headache worse lying down (the more common GLP-1 pattern): Suggests relative CSF volume depletion Brain is inadequately cushioned Lying down increases intracranial pressure, stretching pain-sensitive structures Standing allows CSF to drain, reducing pressure Fix: hydration to restore CSF volume Headache worse standing up (less common, but possible): Suggests CSF leak or severe volume depletion Brain sags downward when upright due to inadequate CSF support Lying down allows the brain to float properly again Standing creates traction on meninges and cranial nerves Fix: aggressive hydration, possible imaging to rule out CSF leak The GLP-1 pattern is usually the first type (worse lying down) because the mechanism is relative hypervolemia when supine in the context of chronic mild dehydration

December 2, 2024: Lawsuits Against Wegovy and other GLP-1 Drugs Grow to 1,300 in November Wegovy manufacturer Novo Nordisk is facing a growing number of lawsuits alleging the weight-loss drug led to serious side effects like blood clots, vision loss, and gastrointestinal disorders